A new oral immunotherapy (HI-164OV) using Haemophilus influenzae, has led to the formation of a new vaccine for patients with severe COPD.
Reference:
M. K. Tandon, M. Phillips, G. Waterer, M. Dunkley, P. Comans, R. Clancy. Oral Immunotherapy with inactivated NTHi reduces severity of acute exacerbations in severe COPD. Chest
No comments:
Post a Comment